Showing results (511-520 of 520) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 520 results.
Journal for Immunotherapy of Cancer|February 10, 2019
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancerAlexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, et al.
Nature Communications|February 2, 2023
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapyMarcel P Trefny, Nicole Kirchhammer, Priska Auf der Maur, et al.
The Journal of Experimental Medicine|July 16, 2025
Tumor-instructed glutamine synthesis in cancer-associated fibroblasts promotes pro-tumor macrophagesXiaoyun Li, Sofie Hedlund Møller, Jaeoh Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2025
Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumorsDerrick Broka, Shoshana Klein, Alexei Shir, et al.
Science Immunology|June 5, 2026
Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancerClara Serger, Lucas Rebuffet, Michael T Sandholzer, et al.
Nature Communications|September 30, 2025
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapyDominic Schmid, Bettina Sobottka, Massimiliano Manzo, et al.
JAMA Oncology|April 26, 2019
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung CancerFiamma Berner, David Bomze, Stefan Diem, et al.
Cell|January 20, 2022
Magnesium sensing via LFA-1 regulates CD8+ T cell effector functionJonas Lötscher, Adrià-Arnau Martí I Líndez, Nicole Kirchhammer, et al.
Nature|March 19, 2026
Proteasome-guided haem signalling axis contributes to T cell exhaustionYingxi Xu, Yangtao Shangguan, Yu-Ming Chuang, et al.
Science Translational Medicine|June 14, 2019
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapyChristina Claus, Claudia Ferrara, Wei Xu, et al.
Pageof 52